This article is more than 5 years old. Information may no longer be current.

VIDEO: Prevalence of NASH-induced cirrhosis more than doubled between 1999 and 2012

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO — In this exclusive video from DDW 2016, Naim Alkhouri, MD, a hepatologist from the Cleveland Clinic, discusses the increasing prevalence and burden of nonalcoholic steatohepatitis-induced cirrhosis in the U.S.

“What we showed in our study is that the prevalence of NASH-cirrhosis in the United States more than doubled between 1999 and 2012, and based on 2010 U.S. census data now we estimate that 400,000 people are living with NASH-cirrhosis in the United States,” Alkhouri said. “We also did further analysis looking at the presence of advanced fibrosis ... and now we estimate that probably 4 million people in the United States have advanced fibrosis related to fatty liver disease.”

Reference:

Alkhouri N, et al. Abstract #827. Presented at: Digestive Disease Week; May 21-24, 2016; San Diego.

Disclosures: Alkhouri reports consulting and serving on advisory committees or review panels for Gilead and Intercept, and receiving royalties from and speaking and teaching for AbbVie and Bristol-Myers Squibb.